Successfully defended PhD on the use of rivaroxaban for the treatment of venous thromboembolism under the supervision of Professor Roopen Arya and Dr. Jignesh Patel at the Institute of Pharmaceutical Science, King’s College London in January 2022.

Sub-investigator for the FIRST Registry, a UK wide, multicentre, investigator led, prospective registry that investigated the long-term complications of rivaroxaban for the treatment of VTE.

Population pharmacokinetic modelling of rivaroxaban with a special interest in extremes of bodyweight.